Bipartisan senators introduced legislation Tuesday requiring country-of-origin labels for prescription drugs to address transparency concerns within the global pharmaceutical supply chain.
An Alabama medical advocacy coalition raised the alarm regarding potential Affordable Care Act premium increases, citing concerns for nearly half a million Alabamians.